Destiny Pharma Seeks Partner For Lead Asset XF-73
Destiny CEO Believes Superbug Gel Will Draw Backing
Antimicrobial specialist Destiny Pharma aims to enlist a pharma partner later this year to help advance and launch its lead asset for preventing post-surgical infections.
